Abatacept + Adalimumab Aqvh Interaction
Majorinteraction on record
Description
Increased risk of serious infection when combined with YUSIMRY; concomitant use not recommended in RA patients.
Mechanism
TNF blocker combined with biologic DMARD increases infection risk
Source: NLP:adalimumab-aqvh